
Honasa Consumer Q4 FY25 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
N/A
Margin
N/A
Fundraise
N/A
Order
N/A
Capex
N/A
0 of 0 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
See what Honasa Consumer management said on margin guidance — free account, 30 seconds.
Fundraise plans
See what Honasa Consumer management said on order book — free account, 30 seconds.
Capex plans
Track Honasa Consumer — get its next earnings analysis in your feed
How does Honasa Consumer rank vs peers in Personal Products?
Pro featureHow does Honasa Consumer rank in Personal Products?
Compare Honasa Consumer against every Personal Products company (Q4 FY25) on revenue, margins and earnings-call signals.
Continue your research
What Honasa Consumer's management said in earlier quarters
Others in Personal Products this season
- Anondita Medicare (Q2 FY27)
Revenue (Standalone)** for H1 FY27: ₹5,786.31 Lakhs, up 21.43% YoY from ₹4,765.06 Lakhs in H1 FY26 . Key investor presentation takeaways from Anondita Medicare
- Gillette India (Q2 FY27)
Revenue from operations for the quarter ended 30th September 2026: ₹84,610 lakh (Page 3) . Key results statement takeaways from Gillette India Ltd's Q2 FY27 ear
- Cupid (Q2 FY27)
Q2 FY27 revenue from operations: ₹187.86 Crores, up 122.5% YoY (Q2 FY26: ₹84.45 Crores) [Page 14, 16] . Key investor presentation takeaways from Cupid Ltd's Q2
- Emami (Q2 FY27)
Volume growth for domestic business recorded 43% in Q2 and 26% on a like-to-like basis, indicating strong demand. Key concall takeaways from Emami Ltd's Q2…